# 2025-20649: ITC Investigates Antibody Drugs for Patent Infringement

2025-20649, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest, is a Federal Register notice from International Trade Commission published 2025-11-21, effective 2025-11-21 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-20649
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-20649
- Title: Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
- Type: Notice
- Agencies: International Trade Commission
- Citation: 90 FR 52697
- Published: 2025-11-21
- Effective: 2025-11-21
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

ITC Investigates Antibody Drugs for Patent Infringement

## Summary

The U.S. International Trade Commission got a complaint about certain antibody drug products possibly breaking import rules. Companies involved include Abb Vie and ImmunoGen on one side, and ProfoundBio and Genmab on the other. The Commission wants your thoughts on how this might affect the public before deciding on actions like blocking imports or stopping sales, with a 60-day review period coming up.

## Abstract

Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Antibody Drug Conjugates and Components Thereof and Products Containing the Same, DN 3856; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.

## Effects PRIA read

- Possible import and sales ban for antibody drugs: cost, high. A complaint filed November 18, 2025 by AbbVie Inc. and ImmunoGen (complainants) asks the Commission to issue a limited exclusion order, cease and desist orders, and impose a bond on certain antibody drug conjugates and components during the 60-day Presidential review period under 19 U.S.C. 1337. Th…
- Short public-comment window and filing rules: benefit, low. The Commission is soliciting public-interest comments on whether the requested remedial orders would affect public health and welfare, competition, U.S. production of like articles, and U.S. consumers, and it lists five specific points (use, health/safety/welfare concerns, U.S. replacement articles…

## Related documents

- [2026-20752](https://policyrisk.com/federal-register/2026-20752): Certain Hydrodermabrasion Systems and Components Thereof; Notice of Vacatur of the Commission's Final Determination and Mootness of the Inv…, 2026-10-09
- [2026-20672](https://policyrisk.com/federal-register/2026-20672): Certain Mobile Electronic Devices and Components Thereof; Institution of Investigation, 2026-10-08
- [2026-20609](https://policyrisk.com/federal-register/2026-20609): Oleoresin Paprika From India; Determinations, 2026-10-08
- [2026-20673](https://policyrisk.com/federal-register/2026-20673): Seamless Carbon and Alloy Steel Standard, Line, and Pressure Pipe From Czechia, Russia, South Korea, and Ukraine; Scheduling of Full Five-Y…, 2026-10-08
- [2026-20614](https://policyrisk.com/federal-register/2026-20614): Forged Steel Fittings From India and South Korea; Cancellation of Hearing for Antidumping and Countervailing Duty Reviews, 2026-10-08
- [2026-20349](https://policyrisk.com/federal-register/2026-20349): Railway Tank Cars and Parts Thereof From Mexico; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Prelim…, 2026-10-05

## Sources
- [2025-20649 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/21/2025-20649/notice-of-receipt-of-complaint-solicitation-of-comments-relating-to-the-public-interest)
- [2025-20649 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-21/pdf/2025-20649.pdf)

## Related
- [Previous: 2025-20648, Asset-Based and Non-Asset-Based Third Party Logistics Customs Trade Partnership…](https://policyrisk.com/federal-register/2025-20648)
- [Next: 2025-20650, Competitive Postal Products](https://policyrisk.com/federal-register/2025-20650)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-20649 (as of 2026-06-08).